ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Gilead Sciences, Inc. Transaction History

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP portfolio value:

$742.53M
portfolio value

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP quarter portfolio value change:

-0.19%
quarter

Gilead Sciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -23.18% -3.63M shares -225.91M $61.69 12.03M
Q2 2022 share Decrease -12.97% -2.33M shares -101.78M $61.81 15.66M
Q1 2022 share Increase +324.78% 13.76M shares 762.50M $59.45 18.00M
Q4 2021 share Increase +11441.83% 4.20M shares 305.15M $73.36 4.23M
Q3 2021 share Decrease -94.05% -580.42K shares -39.93M $69.85 36.71K
Q2 2021 share Increase 0.00% 617.14K shares 42.49M $68.17 617.14K
Q1 2021 share Decrease -100.00% -3.08M shares -179.56M $63.33 0
Q4 2020 share Increase +44.51% 949.27K shares 44.79M $56.43 3.08M
Q3 2020 share Increase +7.70% 152.48K shares -17.59M $60.52 2.13M
Q2 2020 share Increase +80.14% 881.06K shares 70.18M $72.94 1.98M
Q1 2020 share Decrease -38.59% -690.81K shares -34.13M $70.22 1.09M
Q4 2019 share Increase +0.79% 14.08K shares 3.75M $60.43 1.79M
Q3 2019 share Decrease -50.58% -1.81M shares -130.25M $58.4 1.77M
Q2 2019 share Increase +10.48% 341K shares 31.33M $61.67 3.59M
Q1 2019 share Increase +175.78% 2.07M shares 137.70M $58.79 3.25M
Q4 2018 share Decrease -11.49% -153.10K shares -29.11M $56.02 1.17M
Q3 2018 share Decrease -46.85% -1.17M shares -74.71M $68.57 1.33M
Q2 2018 share Decrease -21.05% -668.46K shares -61.80M $62.43 2.50M
Q1 2018 share Increase +3.43% 105.42K shares 19.46M $65.91 3.17M
Q4 2017 share Increase +12545.50% 3.04M shares 217.99M $62.19 3.07M
Q3 2017 share Increase 0.00% 24.28K shares 1.96M $69.84 24.28K
Q2 2017 share Decrease -100.00% -864.95K shares -58.74M $60.63 0
Q1 2017 share Increase 0.00% 864.95K shares 58.74M $57.72 864.95K